Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.

Huyong Zheng,Hui Jiang,Shaoyan Hu,Ning Liao,Diying Shen,Xin Tian,Guoping Hao,Runming Jin,Jianxin Li,Yongjun Fang,Xiuli Ju,Ansheng Liu,Ningling Wang,Xiaowen Zhai,Jiashi Zhu,Qun Hu,Limin Li,Liu Wei,Lirong Sun,Li Wang,Yunpeng Dai,Xiaoqin Feng,Fu Li,Hui Liang,Xinhui Luo,Mei Yan,Qingning Yin,Yan Chen,Yueqin Han,Lijun Qu,Yanling Tao,Hui Gao,Zhixu He,Limin Lin,Jixia Luo,Kaili Pan,J. Zhang,Rong Zhang,Min Zhou,Yuanyuan Zhang,Linya Wang,Ruidong Zhang,Peifang Xiao,Yayun Ling,Xiaoxia Peng,Yaguang Peng,Tianyou Wang

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.

2021

PURPOSEArsenic combined with all-trans retinoic acid (ATRA) is the standard of care for adult acute promyelocytic leukemia (APL). However, the safety and effectiveness of this treatment in pediatri...

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations